Search Results - "F. Satler, Lowell"

Vascular Complications After Transcatheter Aortic Valve Replacement by Généreux, Philippe, MD, Webb, John G., MD, Svensson, Lars G., MD, PhD, Kodali, Susheel K., MD, Satler, Lowell F., MD, Fearon, William F., MD, Davidson, Charles J., MD, Eisenhauer, Andrew C., MD, Makkar, Raj R., MD, Bergman, Geoffrey W., MB, BS, Babaliaros, Vasilis, MD, Bavaria, Joseph E., MD, Velazquez, Omaida C., MD, Williams, Mathew R., MD, Hueter, Irene, PhD, Xu, Ke, PhD, Leon, Martin B., MD

“…Objectives This study sought to identify incidence, predictors, and impact of vascular complications (VC) after transfemoral (TF) transcatheter aortic valve…”
Get full text

Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement by Barbash, Israel M., MD, Ben-Dor, Itsik, MD, Dvir, Danny, MD, Maluenda, Gabriel, MD, Xue, Zhenyi, MS, Torguson, Rebecca, MPH, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Background Patients undergoing transcatheter aortic valve replacement (TAVR) are at increased risk for acute kidney injury (AKI). The Valve Academic Research…”
Get full text

Complications and Outcome of Balloon Aortic Valvuloplasty in High-Risk or Inoperable Patients by Ben-Dor, Itsik, MD, Pichard, Augusto D., MD, Satler, Lowell F., MD, Goldstein, Steven A., MD, Syed, Asmir I., MD, Gaglia, Michael A., MD, MSc, Weissman, Gaby, MD, Maluenda, Gabriel, MD, Gonzalez, Manuel A., MD, MPH, Wakabayashi, Kohei, MD, Collins, Sara D., MD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Xue, Zhenyi, MS, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Objectives This study aimed to determine the success, complications, and survival of patients after balloon aortic valvuloplasty (BAV). Background The…”
Get full text

Choice of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Impacts Hemodynamics Differently According to Aortic Annular Size by Rogers, Toby, BM, BCh, PhD, Steinvil, Arie, MD, Gai, Jiaxiang, MSPH, Torguson, Rebecca, MPH, Koifman, Edward, MD, Kiramijyan, Sarkis, MD, Negi, Smita, MD, Lee, Sang Yeub, MD, Okubagzi, Petros, MD, Satler, Lowell F., MD, Ben-Dor, Itsik, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Abstract We sought to determine whether balloon-expandable (BEV) and self-expanding (SEV) valves affect valve hemodynamics differently according to native…”
Get full text

Intracoronary Brachytherapy for Recurrent Drug-Eluting Stent Failure by Negi, Smita I., MD, Torguson, Rebecca, MPH, Gai, Jiaxiang, MSPH, Kiramijyan, Sarkis, MD, Koifman, Edward, MD, Chan, Rosanna, PhD, Randolph, Pamela, MD, Pichard, Augusto, MD, Satler, Lowell F., MD, Waksman, Ron, MD

“…Abstract Objectives The study sought to report safety and long-term clinical efficacy of intravascular brachytherapy (VBT) for recurrent drug-eluting stent…”
Get full text

A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome by Waksman, Ron, MD, Torguson, Rebecca, MPH, Kent, Kenneth M., MD, PhD, Pichard, Augusto D., MD, Suddath, William O., MD, Satler, Lowell F., MD, Martin, Brenda D., RN, Perlman, Timothy J., BSME, Maltais, Jo-Ann B., PhD, Weissman, Neil J., MD, Fitzgerald, Peter J., MD, Brewer, H. Bryan, MD

“…Objectives This study aimed to determine whether serial autologous infusions of selective high-density lipoprotein (HDL) delipidated plasma are feasible and…”
Get full text

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy by McFadden, Eugène P, Stabile, Eugenio, Regar, Evelyn, Cheneau, Edouard, Ong, Andrew TL, Kinnaird, Timothy, Suddath, William O, Weissman, Neil J, Torguson, Rebecca, Kent, Kenneth M, Pichard, August D, Satler, Lowell F, Waksman, Ron, Serruys, Patrick W

“…Although the safety profiles of coronary stents eluting sirolimus or paclitaxel do not seem to differ from those of bare metal stents in the short-to-medium…”
Get full text

Impact of Significant Hemoglobin Drop Without Bleeding in Patients Undergoing Transcatheter Aortic Valve Replacement by Reddy, Pavan, Merdler, Ilan, Zhang, Cheng, Cellamare, Matteo, Ben-Dor, Itsik, Satler, Lowell F, Rogers, Toby, Garcia-Garcia, Hector M, Waksman, Ron

“…Hemoglobin (Hgb) drop without bleeding is common among patients undergoing transcatheter aortic valve replacement; however, the clinical implications of…”
Get full text

Clinical Frailty as an Outcome Predictor After Transcatheter Aortic Valve Implantation by Rogers, Toby, Alraies, M. Chadi, Moussa Pacha, Homam, Bond, Elizabeth, Buchanan, Kyle D., Steinvil, Arie, Gai, Jiaxiang, Torguson, Rebecca, Ben-Dor, Itsik, Satler, Lowell F., Waksman, Ron

“…Society of Thoracic Surgeons (STS) score and frailty index are calculated routinely as part of transcatheter aortic valve implantation (TAVI) assessment to…”
Get full text

Impact of Pre-Procedural Serum Albumin Levels on Outcome of Patients Undergoing Transcatheter Aortic Valve Replacement by Koifman, Edward, MD, Magalhaes, Marco A., MD, Ben-Dor, Itsik, MD, Kiramijyan, Sarkis, MD, Escarcega, Ricardo O., MD, Fang, Chen, PhD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Negi, Smita I., MD, Baker, Nevin C., DO, Minha, Sa'ar, MD, Corso, Paul J., MD, Shults, Christian, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Risk assessment for transcatheter aortic valve replacement (TAVR) patients is challenging, and surgical scores do not optimally correlate with outcome. The aim…”
Get full text

Utility of an additive frailty tests index score for mortality risk assessment following transcatheter aortic valve replacement by Steinvil, Arie, Buchanan, Kyle D., Kiramijyan, Sarkis, Bond, Elizabeth, Rogers, Toby, Koifman, Edward, Shults, Christian, Xu, Linzhi, Torguson, Rebecca, Okubagzi, Petros G., Pichard, Augusto D., Satler, Lowell F., Ben-Dor, Itsik, Waksman, Ron

“…The impact of frailty assessment on outcomes in patients undergoing transcatheter aortic valve replacement (TAVR) remains unclear. Our aim was to evaluate the…”
Get full text

Outcomes of Patients With Chronic Lung Disease and Severe Aortic Stenosis Treated With Transcatheter Versus Surgical Aortic Valve Replacement or Standard Therapy by Dvir, Danny, MD, Waksman, Ron, MD, Barbash, Israel M., MD, Kodali, Susheel K., MD, Svensson, Lars G., MD, PhD, Tuzcu, E. Murat, MD, Xu, Ke, PhD, Minha, Sa'ar, MD, Alu, Maria C, Szeto, Wilson Y., MD, Thourani, Vinod H., MD, Makkar, Raj, MD, Kapadia, Samir, MD, Satler, Lowell F., MD, Webb, John G., MD, Leon, Martin B., MD, Pichard, Augusto D., MD

“…Objectives The study aimed to evaluate the impact of chronic lung disease (CLD) on outcomes of severe aortic stenosis patients across all treatment modalities…”
Get full text

Prevalence and Impact of Pulmonary Hypertension on Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement by Barbash, Israel M., MD, Escarcega, Ricardo O., MD, Minha, Sa'ar, MD, Ben-Dor, Itsik, MD, Torguson, Rebecca, MPH, Goldstein, Steven A., MD, Wang, Zuyue, MD, Okubagzi, Petros, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Limited amount of data suggest that patients with aortic stenosis and pulmonary hypertension (PH) who undergo transcatheter aortic valve replacement (TAVR)…”
Get full text

Comparison of Outcomes After Percutaneous Coronary Intervention Among Different Coronary Subsets (Stable and Unstable Angina Pectoris and ST-Segment and Non-ST-Segment Myocardial Infarction) by Loh, Joshua P., MBBS, Pendyala, Lakshmana K., MD, Kitabata, Hironori, MD, PhD, Torguson, Rebecca, MPH, Omar, Alfazir, MBChB, Minha, Sa'ar, MD, Chen, Fang, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Percutaneous coronary intervention in the setting of acute myocardial infarction is known to predict stent thrombosis (ST). This study aims to compare the ST…”
Get full text

Prevalence and Effect of Myocardial Injury After Transcatheter Aortic Valve Replacement by Barbash, Israel M., MD, Dvir, Danny, MD, Ben-Dor, Itsik, MD, Badr, Salem, MD, Okubagzi, Petros, MD, Torguson, Rebecca, MPH, Corso, Paul J., MD, Xue, Zhenyi, MS, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…The incidence and prognostic implication of myocardial injury after transcatheter aortic valve replacement (TAVR) have not been consistently studied. We aimed…”
Get full text

Impact of Right Ventricular Function on Outcome of Severe Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Replacement by Koifman, Edward, MD, Didier, Romain, MD, Patel, Nirav, MD, Jerusalem, Zack, MD, Kiramijyan, Sarkis, MD, Ben-Dor, Itsik, MD, Negi, Smita I, MD, Wang, Zuyue, MD, Goldstein, Steven A, MD, Lipinski, Michael J., MD, PhD, Torguson, Rebecca, MPH, Gai, Jiaxiang, MSPH, Pichard, Augusto D., MD, Satler, Lowell F., MD, Waksman, Ron, MD, Asch, Federico, MD

“…Abstract Background Right ventricular (RV) dysfunction was shown to be associated with adverse outcomes in a variety of cardiac patients and is considered a…”
Get full text

Impact of Blood Transfusions on Short- and Long-Term Mortality in Patients Who Underwent Transcatheter Aortic Valve Implantation by Escárcega, Ricardo O., MD, Lipinski, Michael J., MD, PhD, Magalhaes, Marco A., MD, Baker, Nevin C., DO, Minha, Sa'ar, MD, Okubagzi, Petros G., MD, Torguson, Rebecca, MPH, Chen, Fang, PhD, Ben-Dor, Itsik, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Baseline anemia is associated with transfusions and increased risk of mortality in patients who underwent cardiac surgery and percutaneous coronary…”
Get full text

Impact of “Nuisance” Bleeding on Clopidogrel Compliance in Patients Undergoing Intracoronary Drug-Eluting Stent Implantation by Roy, Probal, MD, Bonello, Laurent, MD, Torguson, Rebecca, MPH, de Labriolle, Axel, MD, Lemesle, Gilles, MD, Slottow, Tina L. Pinto, MD, Steinberg, Daniel H., MD, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Suddath, William O., MD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Premature cessation of clopidogrel is a strong risk factor for drug-eluting stent thrombosis in patients undergoing percutaneous coronary intervention. The…”
Get full text

Clinical Profile, Prognostic Implication, and Response to Treatment of Pulmonary Hypertension in Patients With Severe Aortic Stenosis by Ben-Dor, Itsik, MD, Goldstein, Steven A., MD, Pichard, Augusto D., MD, Satler, Lowell F., MD, Maluenda, Gabriel, MD, Li, Yanlin, MD, Syed, Asmir I., MD, Gonzalez, Manuel A., MD, MPH, Gaglia, Michael A., MD, MSc, Wakabayashi, Kohei, MD, Delhaye, Cedric, MD, Belle, Loic, MD, Wang, Zuyue, MD, Collins, Sara D., MD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Aderotoye, Adefolaseyi, MS, Xue, Zhenyi, MS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Epstein, Stephen E., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…The incidence, correlates, and prognostic implications of pulmonary hypertension (PH) are unclear in patients with severe aortic stenosis (AS). We studied 509…”
Get full text

Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions by Kinnaird, Timothy D, Stabile, Eugenio, Mintz, Gary S, Lee, Cheol Whan, Canos, Daniel A, Gevorkian, Natalie, Pinnow, Ellen E, Kent, Kenneth M, Pichard, Augusto D, Satler, Lowell F, Weissman, Neil J, Lindsay, Joseph, Fuchs, Shmuel

“…Bleeding related to percutaneous coronary intervention (PCI) occurs relatively frequently. We retrospectively investigated the incidence, predictors, and…”
Get full text